|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61K 9/00 | |||
| A61K 45/06 | |||
| A61K 38/43 | |||
| A61P 35/00 | |||
| A61P 15/00 | |||
| A61P 43/00 |
| (11) | Number of the document | 2968484 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14721664.2 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/029448 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/144859 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361790070 P | 2013-03-15 | US |
| (72) |
LEPPERT, Phyllis, Carolyn, US
WEGMAN, Thomas, L., US
|
| (73) |
BioSpecifics Technologies Corporation,
35 Wilbur Street, Lynbrook, NY 11563,
US
Duke University, 35 Wilbur Street, Durham, NC 27708, US |
| (54) | TREATMENT METHOD AND PRODUCT FOR UTERINE FIBROIDS USING PURIFIED COLLAGENASE |
| TREATMENT METHOD AND PRODUCT FOR UTERINE FIBROIDS USING PURIFIED COLLAGENASE |